Synapse - Kevin Staton

Results (14)

Epichaperome-targeted myocardial imaging by (124)I-PU-H71 PET

Journal Article

Mahajan, S.; Grkovski, M.; Staton, K. D.; Ravassa, S.; Domfe, K.; Strauss, H. W.; Humm, J. L.; Zanzonico, P. B.; Beattie, B. J.; Cho, I.; more...
Clinical and Translational Imaging (2024)

Fulltext@MSK | Save

Preclinical evaluation of (89)Zr-Df-IAB22M2C PET as an imaging biomarker for the development of the GUCY2C-CD3 bispecific PF-07062119 as a T cell engaging therapy

Journal Article

Maresca, K. P.; Chen, J.; Mathur, D.; Giddabasappa, A.; Root, A.; Narula, J.; King, L.; Schaer, D.; Golas, J.; Kobylarz, K.; more...
Molecular Imaging and Biology (2021)

Fulltext@MSK | Save

First-in-humans trial of dasatinib-derivative tracer for tumor kinase-targeted PET

Journal Article

Krebs, S.; Veach, D. R.; Carter, L. M.; Grkovski, M.; Fornier, M.; Mauro, M. J.; Voss, M. H.; Danila, D. C.; Burnazi, E.; Null, M.; more...
Journal of Nuclear Medicine (2020)

Fulltext@MSK | Save

Preclinical evaluation of (89)Zr-Df-IAB22M2C PET as a potential imaging biomarker in targeted immuno-therapeutic drug development of a GUCY2C-CD3 bispecific antibody PF-07062119

Meeting Abstract

Maresca, K.; Chen, J.; Mathur, D.; Giddabasappa, A.; Root, A.; Narula, J.; King, L.; Schaer, D.; Golas, J.; Rosfjord, E.; more...
Journal of Nuclear Medicine (2020)

Fulltext@MSK | Save

Pharmacokinetic assessment of (18)F-(2S,4R)-4-fluoroglutamine in patients with cancer

Journal Article

Grkovski, M.; Goel, R.; Krebs, S.; Staton, K. D.; Harding, J. J.; Mellinghoff, I. K.; Humm, J. L.; Dunphy, M. P. S.
Journal of Nuclear Medicine (2020)

Fulltext@MSK | Save

Phase I trial of well-differentiated neuroendocrine tumors (NETs) with radiolabeled somatostatin antagonist (177)Lu-satoreotide tetraxetan

Journal Article

Reidy-Lagunes, D.; Pandit-Taskar, N.; O'Donoghue, J. A.; Krebs, S.; Staton, K. D.; Lyashchenko, S. K.; Lewis, J. S.; Raj, N.; Gönen, M.; Lohrmann, C.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Assessment of simplified methods for quantification of (18)F-FDHT uptake in patients with metastatic castration-resistant prostate cancer

Journal Article

Kramer, G. M.; Yaqub, M.; Vargas, H. A.; Schuit, R. C.; Windhorst, A. D.; van den Eertwegh, A. J. M.; van der Veldt, A. A. M.; Bergman, A. M.; Burnazi, E. M.; Lewis, J. S.; more...
Journal of Nuclear Medicine (2019)

Fulltext@MSK | Save

Preclinical development and first-in-human imaging of 89Zr-daratumumab for CD38 targeted imaging of myeloma

Meeting Abstract

Ulaner, G.; Sobol, N.; O'Donoghue, J.; Burnazi, E.; Staton, K.; Weber, W.; Lyashchenko, S.; Lewis, J.; Landgren, C. O.
Journal of Nuclear Medicine (2019)

Fulltext@MSK | Save

Reproducibility and repeatability of semiquantitative (18)F-fluorodihydrotestosterone uptake metrics in castration-resistant prostate cancer metastases: A prospective multicenter study